NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
出版年份 2015 全文链接
标题
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
作者
关键词
-
出版物
Biomed Research International
Volume 2015, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2015-06-17
DOI
10.1155/2015/178698
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
- (2015) Xiaosong Wu et al. NEOPLASIA
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- Reactive Oxygen Species– and DNA Damage Response–Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1
- (2014) Alessandra Soriani et al. JOURNAL OF IMMUNOLOGY
- GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target
- (2014) N I Herath et al. Blood Cancer Journal
- Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
- (2013) N. Fiegler et al. BLOOD
- DNA repair pathways in human multiple myeloma
- (2013) Claire Gourzones-Dmitriev et al. CELL CYCLE
- Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
- (2013) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- Heat Shock Protein 90 Is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells
- (2013) J. Bae et al. JOURNAL OF IMMUNOLOGY
- IMWG consensus on maintenance therapy in multiple myeloma
- (2012) H. Ludwig et al. BLOOD
- Allogeneic hematopoietic stem cell transplantation for multiple myeloma
- (2012) Guenther Koehne et al. CURRENT OPINION IN ONCOLOGY
- The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases
- (2012) Britta Lamottke et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells
- (2012) KOJI YAMANEGI et al. ONCOLOGY REPORTS
- Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
- (2012) H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib
- (2012) T Ishii et al. Blood Cancer Journal
- Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression
- (2011) Xiulong Xu et al. BMC CANCER
- Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
- (2011) R. Bedel et al. CANCER RESEARCH
- Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
- (2011) S. Textor et al. CANCER RESEARCH
- Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
- (2011) Hai Li et al. CELL CYCLE
- Degradation-linked ubiquitin signal and proteasome are integral components of DNA double strand break repair: New perspectives for anti-cancer therapy
- (2011) Kristijan Ramadan et al. FEBS LETTERS
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
- (2011) Baocheng Huang et al. JOURNAL OF IMMUNOTHERAPY
- Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
- (2011) Lucas E. Rossi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and ‘retreatment’ approaches in the era of novel agents
- (2011) B Mohty et al. LEUKEMIA
- SUMO in the mammalian response to DNA damage: Figure 1
- (2010) Joanna R. Morris BIOCHEMICAL SOCIETY TRANSACTIONS
- Pharmaceutical inhibition of glycogen synthetase kinase-3 reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model
- (2010) W. G. Gunn et al. BLOOD
- Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
- (2010) Francesco Piazza et al. BMC CANCER
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- Glycogen synthase kinase 3: A point of convergence for the host inflammatory response
- (2010) Huizhi Wang et al. CYTOKINE
- The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells
- (2010) Xiaoli Feng et al. MOLECULAR IMMUNOLOGY
- Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
- (2009) K. Kohga et al. CANCER RESEARCH
- Regulatory ubiquitylation in response to DNA double-strand breaks
- (2009) Stephanie Panier et al. DNA REPAIR
- Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma
- (2009) Martin Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity
- (2009) X. Wang et al. HAEMATOLOGICA
- Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
- (2009) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- TNF-α-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species
- (2009) A M Vahdat et al. LEUKEMIA
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
- (2009) Joanna R. Morris et al. NATURE
- Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks
- (2009) Yaron Galanty et al. NATURE
- Induction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine
- (2008) Kai-Fu Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
- (2008) Eléonore Beurel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3
- (2008) Ying Zhou et al. LEUKEMIA & LYMPHOMA
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now